ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 185,62
0,09%
Dow Jones
44 722,06
-0,31%
DAX
19 422,03
-0,01%
Brent Oil
72,155
-0,72%
Bitcoin
96 668,08
1,06%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Molecular Templates Inc (MTEM)

  7. Molecular Templates Inc (MTEM) Actualités

MTEM

Molecular Templates (MTEM)

Molecular Templates Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MTEM
DateHeureSourceTitreSymboleSociété
26/11/202422h35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MTEMMolecular Templates Inc
26/11/202422h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MTEMMolecular Templates Inc
15/11/202412h05Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:MTEMMolecular Templates Inc
12/11/202415h31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MTEMMolecular Templates Inc
28/10/202422h20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MTEMMolecular Templates Inc
17/10/202423h05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:MTEMMolecular Templates Inc
30/09/202423h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
14/08/202422h36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MTEMMolecular Templates Inc
14/08/202422h21GlobeNewswire Inc.Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate UpdateNASDAQ:MTEMMolecular Templates Inc
13/08/202422h47Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MTEMMolecular Templates Inc
03/06/202414h11GlobeNewswire Inc.Molecular Templates, Inc. Provides Interim UpdateNASDAQ:MTEMMolecular Templates Inc
15/05/202423h11GlobeNewswire Inc.Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate UpdateNASDAQ:MTEMMolecular Templates Inc
09/04/202414h11GlobeNewswire Inc.Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer PatienNASDAQ:MTEMMolecular Templates Inc
29/03/202413h21GlobeNewswire Inc.Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
28/03/202413h11GlobeNewswire Inc.Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase AgreementNASDAQ:MTEMMolecular Templates Inc
15/02/202402h39Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MTEMMolecular Templates Inc
14/02/202422h45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MTEMMolecular Templates Inc
08/02/202423h55GlobeNewswire Inc.Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:MTEMMolecular Templates Inc
13/11/202322h11GlobeNewswire Inc.Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
02/11/202321h11GlobeNewswire Inc.Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid TumorsNASDAQ:MTEMMolecular Templates Inc
01/11/202321h12GlobeNewswire Inc.Molecular Templates to Participate in Upcoming Investor ConferencesNASDAQ:MTEMMolecular Templates Inc
06/10/202323h08Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
28/09/202322h11GlobeNewswire Inc.Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical OfficerNASDAQ:MTEMMolecular Templates Inc
21/08/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MTEMMolecular Templates Inc
11/08/202317h22GlobeNewswire Inc.Molecular Templates Announces 1-for-15 Reverse Stock SplitNASDAQ:MTEMMolecular Templates Inc
10/08/202315h01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MTEMMolecular Templates Inc
10/08/202314h08GlobeNewswire Inc.Molecular Templates, Inc. Reports Second Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
02/08/202322h11GlobeNewswire Inc.Molecular Templates Announces Executive Leadership ChangesNASDAQ:MTEMMolecular Templates Inc
31/07/202322h28Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:MTEMMolecular Templates Inc
13/07/202314h14GlobeNewswire Inc.Molecular Templates Announces Up to $40 Million Private Placement OfferingNASDAQ:MTEMMolecular Templates Inc
 Showing the most relevant articles for your search:NASDAQ:MTEM

Dernières Valeurs Consultées

BOV
EBAY34R
EBay
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés

BLACK FRIDAY

ADVFN

Célébrons nos 25 ans Est 1999-2024

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Cours Euronext en temps réel et illimités sur le site. Carnet d'ordres Euronext en direct